The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Three-Year Multicenter Surveillance of Pneumococcal Meningitis in Children: Clinical Characteristics, and Outcome Related to Penicillin Susceptibility and Dexamethasone Use
Abstract
Objectives.: To evaluate the antibiotic susceptibility of Streptococcus pneumoniae isolates obtained from the blood and cerebrospinal fluid of children with meningitis. To describe and compare the clinical and microbiological characteristics, treatment, and outcome of children with meningitis caused by S pneumoniae based on antimicrobial susceptibility of isolates and the administration of dexamethasone. Design and Patients.: Children with pneumococcal meningitis were identified from among a group of patients with systemic infections caused by S pneumoniae who were enrolled prospectively in the United States Pediatric Multicenter Pneumococcal Surveillance Study at eight children's hospitals in the United States. From September 1, 1993 to August 31, 1996, 180 children with 181 episodes of pneumococcal meningitis were identified and data were collected by retrospective chart review. Outcome.: Clinical and laboratory characteristics were assessed. All pneumococcal isolates were serotyped and antibiotic susceptibilities for penicillin and ceftriaxone were determined. Clinical presentation, hospital course, and outcome parameters at discharge were compared between children infected with penicillin-susceptible isolates and those with nonsusceptible isolates and for children who did and did not receive dexamethasone. Results.: Fourteen (7.7%) of 180 children died; none of the fatalities were because of a documented failure of treatment caused by a resistant strain. Only 1 child, who had mastoiditis and a lymphangioma, experienced a bacteriologic failure with a penicillin-resistant (minimum inhibitory concentration = 2 μg/mL) organism. Of the 166 surviving children, 41 (25%) developed neurologic sequelae (motor deficits) and 48 (32%) of 151 children had unilateral (n = 26) or bilateral (n = 22) moderate to severe hearing loss at discharge. Overall, 12.7% and 6.6% of the pneumococcal isolates were intermediate and resistant to penicillin and 4.4% and 2.8% were intermediate and resistant to ceftriaxone, respectively. Clinical presentation, cerebrospinal fluid indices on admission, and hospital course, morbidity, and mortality rates were similar for patients infected with penicillin- or ceftriaxone-susceptible versus nonsusceptible organisms. However, the relatively small numbers of nonsusceptible isolates and the inclusion of vancomycin in the treatment regimen for the majority of the patients limit the power of this study to detect significant differences in outcome between patients infected with susceptible and nonsusceptible isolates. Nonetheless, our results show that the nonsusceptible organisms do not seem to be intrinsically more virulent. Forty children (22%) received dexamethasone (≥8 doses) initiated before or within 1 hour after the first dose of antibiotics. The incidence of any moderate or severe hearing loss was significantly higher in the dexamethasone group (46%) compared with children not receiving any dexamethasone (23%). The incidence of any neurologic deficits, including hearing loss, also was significantly higher in the dexamethasone group (55% vs 33%). However, children in the dexamethasone group more frequently required intubation and mechanical ventilation and had lower initial concentration of glucose in the cerebrospinal fluid than children who did not receive any dexamethasone. When we controlled for the confounding factor, severity of illness (intubation), the incidence of any deafness and of any neurologic sequelae, including deafness, were no longer significantly different between children who did or did not receive dexamethasone. Conclusions.: Children with pneumococcal meningitis caused by penicillin- or ceftriaxone-nonsusceptible organisms and those infected by susceptible strains had similar clinical presentation and outcome. The use of dexamethasone was not associated with a beneficial effect in this retrospective and nonrandomized study. Only a well-designed, prospective, randomized, placebo-controlled study, conducted in centers where optimal supportive care can be provided, will determine the potential benefit, if any, of dexamethasone in patients with pneumococcal meningitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., & Gudiol, F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330802 · Cited by 773
Glucocorticoids Potentiate Ischemic Injury to Neurons: Therapeutic Implications
Sapolsky, R. M., & Pulsinelli, W. A. (1985) · Science · doi:10.1126/science.4035356 · Cited by 676
Dexamethasone Therapy for Bacterial Meningitis
Lebel, M. H., Freij, B. J., Syrogiannopoulos, G. A., Chrane, D. F., Hoyt, M. J., Stewart, S. M., Kennard, B. D., Olsen, K. D., & McCracken, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191502 · Cited by 606
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
The Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330803 · Cited by 503
Odio, C. M., Faingezicht, I., Paris, M., Nassar, M., Baltodano, A., Rogers, J., Sáez-Llorens, X., Olsen, K. D., & McCragken, G. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242201 · Cited by 501
Outcomes of bacterial meningitis in children: a meta-analysis
BARAFF, L. J., LEE, S. I., & SCHRIGER, D. L. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00008 · Cited by 495
Bacterial Meningitis in the United States, 1986: Report of a Multistate Surveillance Study
Wenger, J. D., Hightower, A. W., Facklam, R. R., Gaventa, S., Broome, C. V., & the Bacterial Meningitis Study Group (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1316 · Cited by 460
McIntyre, P. B. (1997) · JAMA · doi:10.1001/jama.278.11.925 · Cited by 416
The Promise and Problems of Meta-Analysis
Bailar, J. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370810 · Cited by 402
Pathogenesis of Pneumococcal Infection
Tuomanen, E. I., Austrian, R., & Masure, H. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321907 · Cited by 381
Prospective Evaluation of Hearing Impairment as a Sequela of Acute Bacterial Meningitis
Dodge, P. R., Davis, H., Feigin, R. D., Holmes, S. J., Kaplan, S. L., Jubelirer, D. P., Stechenberg, B. W., & Hirsh, S. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410043111401 · Cited by 348
Self-citationPeltola, H., Kilpi, T., Anttila, M., Peltola, H., & Kilpi, T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92117-x · Cited by 344
Butler, J. C., Hofman, J., Cetron, M. S., Elliott, J. A., Facklam, R. R., Breiman, R. F., & Pneumococcal Sentinel Surveillance Working Group (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.986 · Cited by 341
Talan, D. A., Moran, G. J., & Pinner, R. W. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70282-9 · Cited by 292
Dexamethasone treatment for bacterial meningitis in children and adults
GIRGIS, N. I., FARID, Z., MIKHAIL, I. A., FARRAG, I., SULTAN, Y., & KILPATRICK, M. E. (1989) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198912000-00004 · Cited by 268
Sloas, M. M., Ff, B., Chesney, P. J., Bk, E., Bc, H., Tenover, F. C., & Rj, L. (1992) · PubMed · Cited by 258
Epidemiology of Invasive Pneumococcal Infections in Children in Finland
Eskola, J. (1992) · JAMA · doi:10.1001/jama.1992.03490230053027 · Cited by 253
Butler, J. C., Breiman, R. F., Lipman, H. B., Hofmann, J., & Facklam, R. R. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.885 · Cited by 250
Evaluation of vancomycin for therapy of adult pneumococcal meningitis
Viladrich, P. F., Gudiol, F., Liñares, J., Pallarés, R., Sabaté, I., Rufí, G., & Ariza, J. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2467 · Cited by 248
Bradley, J. S., & Connor, J. D. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199111000-00018 · Cited by 238
Self-citationBradley, J. S., & Connor, J. D. (1991) · PubMed · Cited by 217
Self-citationDexamethasone therapy for bacterial meningitis in children
Schaad, U. B., Wedgwood, J., Lips, U., Gnehm, H. E., Heinzer, I., & Blumberg, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)91592-a · Cited by 215
John, C. C. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.188 · Cited by 204
Zangwill, K. M., Vadheim, C. M., Vannier, A. M., Hemenway, L. S., Greenberg, D. P., & Ward, J. I. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.4.752 · Cited by 200
Dexamethasone Therapy for Children With Bacterial Meningitis
Wald, E. R., Kaplan, S. L., Mason, E. O., Sabo, D., Md, L. R., Arditi, M., Wiedermann, B. L., Barson, W., Kim, K. S., Yogev, R., et al. (1995) · Pediatrics · doi:10.1542/peds.95.1.21 · Cited by 180
Self-citationThree-Year Multicenter Surveillance of Systemic Pneumococcal Infections in Children
Kaplan, S. L., Mason, E. O., Barson, W. J., Wald, E. R., Arditi, M., Tan, T. Q., Schutze, G. E., Bradley, J. S., Givner, L. B., Kim, K. S., et al. (1998) · Pediatrics · doi:10.1542/peds.102.3.538 · Cited by 175
Self-citationTherapy for Children With Invasive Pneumococcal Infections
Committee on Infectious Diseases (1997) · Pediatrics · doi:10.1542/peds.99.2.289 · Cited by 174
Zysk, G., Brück, W., Gerber, J., Brück, Y., Prange, H. W., & Nau, R. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199606000-00006 · Cited by 163
Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis
Friedland, I. R., Shelton, S., Paris, M. M., Rinderknecht, S. B., Ehrett, S., Krisher, K., & McCracken, G. H. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199303000-00004 · Cited by 151
Pneumococcal Meningitis in Children: Prognostic Indicators and Outcome
Kornelisse, R. F., Westerbeek, C., Spoor, A. B., van der Heijde, B., Spanjaard, L., Neijens, H. J., & de Groot, R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1390 · Cited by 142
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae
Paris, M. M., Ramilo, O., & McCracken, G. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2171 · Cited by 128
MORTALITY FROM PNEUMOCOCCAL MENINGITIS
Baird, D., Whittle, H. C., & Greenwood, B. M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91985-1 · Cited by 117
Beneficial effects of dexamethasone in children with pneumococcal meningitis
Kanra, G., Özen, H., Secmeer, G., Ceyhan, M., Ecevit, Z., & Belgi̇n, E. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199506000-00005 · Cited by 114
The Role of Corticosteroid Therapy in Children With Pneumococcal Meningitis
Kennedy, W. A. I. (1991) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1991.02160120042016 · Cited by 101
Tan, T. Q., Schutze, G. E., Mason, E. O., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.918 · Cited by 95
Self-citationBohr, V. A., Rasmussen, N., Hansen, B., Gade, A., Kjersem, H., Johnsen, N. J., & Paulson, O. B. (1985) · Journal of Infection · doi:10.1016/s0163-4453(85)91585-3 · Cited by 73
Prognostic factors in pneumococcal meningitis.
Weiss, W., Figueroa, W., Shapiro, W. H., et al. (1967) · PubMed · Cited by 72
The Biology of Pneumococcal Infection
TUOMANEN, E. I. (1997) · Pediatric Research · doi:10.1203/00006450-199709000-00001 · Cited by 72
Diab, A., Zhu, J., Lindquist, L., Wretlind, B., Bakhiet, M., & Link, H. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4441343.x · Cited by 60
Eradication of Haemophilus influenzae Type b Disease in Southern California
Vadheim, C. M. (1994) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1994.02170010053011 · Cited by 57
Tan, T. Q., Smith, C. W., Hawkins, E. P., Mason, E. O., & Kaplan, S. L. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.342 · Cited by 55
Self-citationBradley, J. S., Kaplan, S. L., Klugman, K. P., & Leggiadro, R. J. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199512000-00002 · Cited by 50
Self-citationPneumococcal Meningitis in Children
Laxer, R. M., & Marks, M. I. (1977) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1977.02120210028004 · Cited by 50
Limoges, J., Persidsky, Y., Bock, P. J., & Gendelman, H. E. (1997) · The Journal of Infectious Diseases · doi:10.1086/516469 · Cited by 27
Chesney, P. J., Davis, Y., English, B. K., & Wang, W. C. (1995) · PubMed · Cited by 23
&NA; (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199511000-00023 · Cited by 21
Examination Findings in Legally Confirmed Child Sexual Abuse: It's Normal to be Normal
Hobbs, C. J., & Wynne, J. M. (1996) · PEDIATRICS · doi:10.1542/peds.97.1.148a · Cited by 9
Cited by
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Self-citationJoint Committee on Infant Hearing (2007) · Pediatrics · doi:10.1542/peds.2007-2333 · Cited by 2,056
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
Edmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631
Metadata
- Authors
- Arditi, M., Mason, E. O., Bradley, J. S., Tan, T. Q., Barson, W. J., Schutze, G. E., Wald, E. R., Givner, L. B., Kim, K. S., Yogev, R., & Kaplan, S. L.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1998-11-01
- Volume
- 102
- Issue
- 5
- Pages
- 1087-1097
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2075823595
- Cited by
- 313
- References
- 50
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.